Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHSBT has a requirement for targeted cell lineage separation for use within NHSBT Diagnostic Functions.
NHSBT must to be able to perform targeted cell lineage separation:
To ensure that NHSBT meet its legal duties and complies with all regulatory and internal quality procedures for diagnostic testing and to ensure best value for money
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| MILTENYI BIOTEC LIMITED | 03096272 | £250,000 | - |
Government spending data: This supplier has received £855,511 in 169 payments (over £25k) from DEFRA, Guy's and St Thomas' NHS FT, Manchester University NHS Foundation Trust, UKRI, Plymouth Hospitals NHS Trust (2023-01-12 to 2026-03-31). View full payment history →